MarliseRachaelLuskinMDMSCE

PubMed

• Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients.
  Julia Keating, Donna S Neuberg, R Coleman Lindsley, Shai Shimony, Jacqueline S Garcia, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Daniel J DeAngelo, Richard M Stone> ;Leukemia. 2024 Mar 27
• Race/ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemia.
  Andrew M Brunner, Jesse J Plascak, Hajime Uno, Juan C Varela, Timothy R Rebbeck, Andrew Hantel, Marlise R Luskin, Richard M Stone, Christopher S Lathan, Daniel J DeAng...> ;Journal of the National Cancer Institute. 2024 Mar 22
• Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts.
  Olesinski, E., Bhatia, K., Wang, C., Pioso, M., Lin, X., Mamdouh, A., Ng, S., Sandhu, V., Jasdanwala, S., Yilma, B., Bohl, S., Ryan, J., Malani, D., Luskin, M., Kallio...> ;Blood Cancer Discovery. 2024 Mar 4
• NeuroinvasiveInfection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid Leukemia.
  Jessica S Little, Cassie Coughlin, Candace Hsieh, Meaghan Lanza, Wan Yi Huang, Aishwarya Kumar, Tanvi Dandawate, Robert Tucker, Paige Gable, Axel A Vazquez Deida, Heat...> ;Open Forum Infectious Diseases. 2024 Mar 1
• 1 citations
  Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia.
  Lane, A., Garcia, J., Raulston, E., Garzon, J., Galinsky, I., Baxter, E., Leonard, R., DeAngelo, D., Luskin, M., Reilly, C., Stahl, M., Stone, R., Vedula, R., Wadleigh...> ;Blood Advances. 2024 Feb 13
• 3 citations
  Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI ...
  Valtis, Y., Flamand, Y., Shimony, S., Place, A., Silverman, L., Vrooman, L., Brunner, A., Sallan, S., Wadleigh, M., Stone, R., DeAngelo, D., Luskin, M.> ;Leukemia. 2024 Mar 1
• Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
  Sam Sadigh, Daniel J DeAngelo, Jacqueline S Garcia, Robert P Hasserjian, Christopher B Hergott, Andrew A Lane, Scott B Lovitch, Fabienne Lucas, Marlise R Luskin, Eliza...> ;Modern Pathology. 2024 Jan 1
• Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies.
  Stevens, M., Kimmerling, R., Olcum, S., Vacha, M., LaBella, R., Minnah, A., Katsis, K., Fujii, J., Shaheen, Z., Sundaresan, S., Criscitiello, J., Niesvizky, R., Raje, ...> ;JCO Precision Oncology. 2024 Jan 1
• Acute lymphoblastic leukemia with myeloid mutations is a high-risk disease associated with clonal hematopoiesis.
  Patel, A. A., Caner Saygin, Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S Sperling, Lachelle D Weeks, Marlise R Luskin, Todd C Knepper, Pankhuri Wanjari, Peng Wang, ...> ;Blood Cancer Discovery. 2023 Dec 27
• Unraveling KMT2A-rearranged ALL.
  Shai Shimony, Marlise R Luskin> ;Blood. 2023 Nov 23
• SOHO State of the Art Updates and Next Questions | Approach to Older Adults With Phildadelphia-Chromosome Negative Acute Lymphoblastic Leukemia.
  Shai Shimony, Marlise R Luskin> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Mar 1
• 1 citations
  Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma.
  Paolino, J., Dimitrov, B., Apsel Winger, B., Sandoval-Perez, A., Rangarajan, A., Ocasio-Martinez, N., Tsai, H., Li, Y., Robichaud, A., Khalid, D., Hatton, C., Gillani,...> ;Clinical Cancer Research. 2023 Nov 14
• Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing.
  Ali AlJabban, Henry Paik, Jon C Aster, Nancy Berliner, Jennifer Brouillard, Jennifer R Brown, Kathleen H Burns, Jorge J Castillo, James Card, Paola Dal Cin, Daniel J D...> ;JCO Oncology Practice. 2024 Feb 1
• Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia.
  Gerard Giblin, Yiwen Liu, Eric S Winer, Jacqueline S Garcia, Evan Chen, Martha Wadleigh, Kelly Ling, R Coleman Lindsley, Shai Shimony, Kevin Copson, Anne Charles, Dani...> ;Leukemia Research. 2023 Sep 1
• 2 citations
  Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials.
  Shai Shimony, Yael Flamand, Yannis K Valtis, Andrew E Place, Lewis B Silverman, Lynda M Vrooman, Andrew M Brunner, Stephen E Sallan, Richard M Stone, Martha Wadleigh, ...> ;Blood Advances. 2023 Sep 26
• 1 citations
  Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia.
  Shai Shimony, Daniel J DeAngelo, Marlise R Luskin> ;Blood Advances. 2024 Jan 9
• 2 citations
  FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years.
  Shai Shimony, Geoffrey Fell, Evan C Chen, Harrison K Tsai, Martha Wadleigh, Eric S Winer, Jacqueline S Garcia, Marlise R Luskin, Donna S Neuberg, Daniel J DeAngelo, R ...> ;Blood Advances. 2023 Sep 26
• 43 citations
  Prediction of risk for myeloid malignancy in clonal hematopoiesis.
  Lachelle D Weeks, Abhishek Niroula, Donna Neuberg, Waihay Wong, R Coleman Lindsley, Marlise Luskin, Nancy Berliner, Richard M Stone, Daniel J DeAngelo, Robert Soiffer,...> ;NEJM Evidence. 2023 May 1
• 34 citations
  A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies.
  Curtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, Tomoyuki Tanaka, Yi June Kim, Hidetaka Uryu, Sven Turkalj, Niels Asger Jakobsen, Marlise R Luskin, Dzifa Y Duose, Rebe...> ;Blood Cancer Discovery. 2023 Jul 5
• 4 citations
  Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial.
  El-Jawahri, A., Luskin, M., Greer, J., Traeger, L., Lavoie, M., Vaughn, D., Andrews, S., Yang, D., Boateng, K., Newcomb, R., Ufere, N., Fathi, A., Hobbs, G., Brunner, ...> ;Cancer. 2023 Apr 1
• 1 citations
  Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm.
  Marlise R Luskin, Andrew A Lane> ;Haematologica. 2024 Jan 1
• Exploring Influencing Factors of Anxiety Improvement Following Mindfulness-Based Music Therapy in Young Adults with Cancer.
  Robert Knoerl, Emanuele Mazzola, Heather Woods, Elizabeth Buchbinder, Lindsay Frazier, Ann LaCasce, Marlise R Luskin, Carolyn S Phillips, Katherine Thornton, Donna L B...> ;Journal of Music Therapy. 2023 Jun 3
• 1 citations
  Exploring Young Adults' Perspectives of Participation in a Mindfulness-Based Music Therapy Intervention Before and During the COVID-19 Pandemic.
  Carolyn S Phillips, Julianna Bockhoff, Donna L Berry, Elizabeth Buchbinder, A Lindsay Frazier, Ann LaCasce, Jennifer Ligibel, Marlise R Luskin, Heather Woods, Robert K...> ;Journal of Adolescent and Young Adult Oncology. 2023 Aug 1
• Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements.
  Robert J Kimmerling, Mark M Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C Wasserman, Juanita Fujii, Zayna Shaheen, Sri...> ;Communications Biology. 2023 Jan 6
• Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantation.
  Hari S Raman, Se Eun Kim, Daniel J DeAngelo, Kristen E Stevenson, Donna Neuberg, Eric S Winer, Martha Wadleigh, Jacqueline S Garcia, Annette S Kim, Richard M Stone, Vi...> ;Leukemia Research. 2023 Feb 1
• Join now to see all

Abstracts/Posters

• Characteristics and Outcome of Patients with Core Binding Factor Acute Myeloid Leukemia and FLT3-ITD: Results from an International Collaboration
  Marlise Luskin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...
  Marlise Luskin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical, Clinical, and Correlative Studies
  Marlise Luskin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Phase I Trial of Escalating Doses of the Bcl-2 Inhibitor Venetoclax in Combination with Daunorubicin/Cytarabine Induction and High Dose Cytarabine Consolidation in Pre...
  Marlise Luskin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute Leukemia 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for Untreated BCR-ABL1-Positive ALL in Older Adults 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Clinical Characteristics of GNB1 and GNAS Mutations in an Unselected Cohort of 6,343 Patients with Hematologic Abnormalities 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• How I Treat Acute Lymphocytic Leukemia: Insight From the Experts 
  60th American Society of Hematology Annual Meeting - 11/30/2018
• Join now to see all